Investigation: the customer states that the patient underwent (b)(4) tube placement and sustained bilateral pneumothorax.A review of the device history record could not be conducted because a lot number was not provided.Manufacturing records are routinely reviewed prior to the release of product to ensure process and product compliance.No samples were received by covidien for evaluation.Because samples were not available for evaluation, the issue reported by the customer could not be confirmed.Root cause analysis stated in the hhe initiation decision advertent bronchopulmonary displacement and consequently pneumothorax of the nasal or oral enteric feeding tubes is a well-studied and well documented complication of current placement techniques for blindly placing the nasal or oral enteric feeding tubes.In the instruction for use (ifu) for the device the warning is clearly provided that an adverse effect likes pneumothorax, intestinal perforation and aspirational pneumonia have been reported during the use of this type of device, therefore due to the extreme caution, this device should only be inserted by a trained clinician.The process to manufacture the device was running according to the defined parameters and specifications.The products met the corresponding quality acceptance criteria.The production personnel were notified about the reported defective condition.Based on the information a corrective action from production perspective is not deemed necessary at this time.We will keep monitoring the process for any adverse trends that require immediate attention.This complaint will be used for tracking and trending purposes.
|